Amylou C Dueck
Datos Biográficos
| ID | 5457763 |
|---|---|
| NOMBRE | Amylou C Dueck |
| NOMBRES | Amylou C |
| APELLIDO | Dueck |
| FIRMA | DUECK A C |
| AFILIACIONES | Mayo Clinic in Arizona |
| ORCID | 0000-0002-9912-1085 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 8 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 8 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2010 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
gov: NCT03249090 (AFT-39), NCT02158637 (MC1091)
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial
Identifying meaningful change on PROMIS short forms in cancer patients
Applying the two-step criteria demonstrated in this study, we determined how much change is needed to declare reliable change at different levels of baseline scores. We offer reference values for percentage of patients who meaningfully change for investigators using the PROMIS instruments in oncology
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and Comet-2
gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2)
Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management
BACKGROUND: Patient-reported outcome (PRO) data may be used at 2 levels: to evaluate impacts of disease and treatment aggregated across individuals (group-level) and to screen/monitor individual patients to inform their management (individual-level). For PRO data to be useful at either level, we need to understand their clinical relevance. PURPOSE: To provide clarity on whether and how methods historically developed to interpret group-based PRO r…
Fracture Risk Perception Study
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
This series of papers provides a path for QOL and genetics researchers to work together to move this field forward and to unravel the intricate interplay of the genetic underpinnings of patient-reported QOL outcomes. The ultimate result will be a greater understanding of the process relating disease, patient, and doctor that will have the potential to lead to improved survival, QOL, and health services delivery
Sin obras prominentes en esta página.
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
This series of papers provides a path for QOL and genetics researchers to work together to move this field forward and to unravel the intricate interplay of the genetic underpinnings of patient-reported QOL outcomes. The ultimate result will be a greater understanding of the process relating disease, patient, and doctor that will have the potential to lead to improved survival, QOL, and health services delivery
Fracture Risk Perception Study
Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management
BACKGROUND: Patient-reported outcome (PRO) data may be used at 2 levels: to evaluate impacts of disease and treatment aggregated across individuals (group-level) and to screen/monitor individual patients to inform their management (individual-level). For PRO data to be useful at either level, we need to understand their clinical relevance. PURPOSE: To provide clarity on whether and how methods historically developed to interpret group-based PRO r…
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and Comet-2
gov Identifiers: NCT02066181 (Alliance A091105); NCT01522443 (COMET-2)
Identifying meaningful change on PROMIS short forms in cancer patients
Applying the two-step criteria demonstrated in this study, we determined how much change is needed to declare reliable change at different levels of baseline scores. We offer reference values for percentage of patients who meaningfully change for investigators using the PROMIS instruments in oncology
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
A 24-hour recall period for PRO-CTCAE items has acceptable measurement properties and can inform day-to-day variations in symptomatic AEs when daily PRO-CTCAE administration is implemented in a clinical trial
Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)
gov: NCT03249090 (AFT-39), NCT02158637 (MC1091)
Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)
Medicine (8 obras) · Psychology (5 obras) · Cancer survivorship and care (4 obras) · Health Systems, Economic Evaluations, Quality of Life (4 obras) · Physical therapy (4 obras) · Public health (4 obras) · Quality of Life Research (4 obras) · Adverse effect (3 obras) · Childhood Cancer Survivors' Quality of Life (3 obras) · Clinical Psychology (3 obras)